MPS Powered by Eureka

Letters in Drug Design & Discovery

ISSN: 1570-1808 (Print)
eISSN: 1875-628X (Online)

Journal
Impact Factor :

1.2

Scopus
CiteScore:

1.8

Aims and Scope:Letters in Drug Design & Discovery publishes letters, full-length/mini-reviews, research articles, highlights and guest edited thematic issues in all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis is on publishing quality papers very rapidly by taking full advantage of the latest Internet technology for both the submission and review of manuscripts. The journal is an essential reading to all pharmaceutical scientists involved in research in drug design and discovery.

Editor-in-Chief:

Ivana Cacciatore
,

Indexed in:


Scopus, SCI Expanded, JCR... View all

Special Issues With Active Call for Papers

Submission closes on: Dec 31, 2025
Navigating the Frontier: Probiotics' Promising Path in Combatting Viral Respiratory Infections, Spotlight on Coronaviridae.

Probiotics, well-known for their role in gut health, show promise in preventing and managing respiratory virus infections, particularly in children and at-risk populations. However, the profound influence of novel pathogenic viral RTIs such as coronaviruses has reshaped perspectives on the potential of probiotics. Despite their potential, significant gaps remain in our understanding, including the viral types and strain-specific effects, mechanisms of action, role of the gut-lung axis, clinical efficacy, population-specific impacts, interactions with other treatments,... see more